Understanding Maintenance Therapy in Breast Cancer
After initial treatments for breast cancer, such as chemotherapy or surgery, the focus often shifts to a “maintenance” or adjuvant phase. Maintenance therapy is a strategic approach designed to keep the cancer stable, prolong the benefits of your initial treatment, and significantly reduce the risk of recurrence.
The Goal of Maintenance
The primary objective is to manage breast cancer as a stable, chronic condition rather than an acute one. By using targeted or endocrine-based therapies, we aim to:
Prolong Disease Stability:Keep the cancer from progressing.
Minimize Recurrence:Actively work to prevent the cancer from returning.
Support Quality of Life:Utilize treatments that are often easier to manage long-term compared to intensive induction chemotherapy.
Expert Insight: “Maintenance isn’t about stopping treatment—it’s about choosing the right, less aggressive tools to keep the cancer at bay while allowing your body to recover and maintain a high quality of life,” notes the NCCN Clinical Practice Guidelines.
Common Maintenance Approaches
Your oncology team tailors your maintenance plan based on the specific “fingerprint” of your breast cancer, including hormone receptor (HR) and HER2 status.
For HR-Positive Disease: The focus is on blocking hormones that may fuel cancer growth.
Endocrine Therapy: Options include tamoxifen or aromatase inhibitors like anastrozole,letrozole, or exemestane.
CDK4/6 Inhibitors: In specific scenarios, drugs like abemaciclib or ribociclib are paired with endocrine therapy to provide an added layer of defense.
For HER2-Positive Disease:Maintenance often involves continuing HER2-targeted therapies, such as trastuzumab +/- pertuzumab, TDM1 or TDxd to keep the disease in check.
For Specific Genetic Profiles:For patients with genetic markers like BRCA1/2, targeted options like olaparib may be incorporated into the plan.
What Decides the Timing and Plan?
Maintenance therapy is not a “one size fits all” approach. Your oncologist determines the start date and drug selection based on:
1. Pathology Results: Your tumor’s grade, receptor status, and node status from your final pathology report.
2. Overall Fitness: Ensuring you have fully recovered from previous treatments and are fit enough to begin maintenance.
3. Treatment History:What therapies you have already completed and how your body responded.
Frequently Asked Questions
Does maintenance therapy mean the cancer is gone?
It means we are actively working to keep the cancer controlled and prevent it from returning, managing it as a stable condition.
Can I take breaks from maintenance therapy?
Your care plan is individualized. Any adjustments, including breaks, must be discussed with your oncology team, who will weigh the risks and benefits.
What should I report to my doctor?
Always report any new, persistent, or worsening symptoms, even if they seem minor, as these help your team ensure your maintenance plan is working safely.
Reference
1. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) – Breast Cancer, Version 2.2026.
Disclaimer:This information is for educational purposes only and does not replace professional medical advice. Always consult your oncology team at your clinic for decisions regarding your specific treatment path.